Parathyroid hormone stimulates prostanoid formation in mouse calvarial bones

Area of Science:

• Endocrinology
• Bone Biology
• Pharmacology

Background:

• Parathyroid hormone (PTH) plays a crucial role in calcium homeostasis and bone metabolism.
• The precise mechanisms by which PTH influences bone cells, particularly regarding prostanoid production, require further elucidation.

Purpose of the Study:

• To investigate the effect of bovine parathyroid hormone (bPTH 1-34) on prostanoid formation in neonatal mouse calvarial bone cells.
• To determine the relationship between PTH-induced prostanoid synthesis and PTH-mediated bone resorption.

Main Methods:

• Primary cultures of neonatal mouse calvarial bones were treated with varying concentrations and durations of bPTH (1-34).
• Prostanoid levels (PGE2 and 6-keto-PGF1 alpha) were measured.
• Calcium-45 (45Ca) release was assessed to quantify bone resorption.
• The effects of indomethacin and calcitonin on these responses were evaluated.
• Synthetic PTH analogues, acting as putative antagonists, were tested for their effects on basal and stimulated prostanoid production.

Main Results:

• bPTH (1-34) significantly enhanced the formation of PGE2 and 6-keto-PGF1 alpha in a time- and dose-dependent manner, with a threshold at 0.1 nmol/l.
• The PGE2 response to bPTH was completely inhibited by indomethacin but unaffected by calcitonin.
• Indomethacin did not inhibit 45Ca release induced by bPTH.
• Putative PTH antagonists did not alter basal PGE2 production or the PGE2 response to bPTH (1-34).

Conclusions:

• PTH stimulates prostanoid formation in mouse bone cells.
• This PTH-induced prostanoid synthesis is pharmacologically distinct from PTH-mediated bone resorption.
• The findings suggest that the prostanoid response is not directly linked to the bone resorptive activity of PTH.